Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

David Newton

Clinical Cardiac Electrophysiology Savannah, GA Medical Doctor

NPI 1598944498 CMS profile 921033

6301 Abercorn St, Savannah, GA 31405

Open in the dashboard

General payments

$224,570

1,336 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$1,189,180 paid to institutions, not to them · program years 2021–2025

Through program year 2025, David Newton of Savannah, GA is reported in the CMS Open Payments database as having received $224,570 across 1,336 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $1,189,180 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 95th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $47,538 237
2024 General $35,693 193
2023 General $77,751 285
2022 General $45,496 257
2021 General $9,698 202
2020 General $3,529 74
2019 General $4,865 88

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • David Newton
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to David Newton were reported at $47,538. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year David Newton Clinical Cardiac Electrophysiology median Middle half National median
2019 $4,865 $2,361 $585–$8,260 $163
2020 $3,529 $993 $247–$4,351 $114
2021 $9,698 $1,185 $326–$4,739 $132
2022 $45,496 $2,073 $554–$6,789 $149
2023 $77,751 $2,568 $759–$8,159 $160
2024 $35,693 $2,557 $703–$7,403 $164
2025 $47,538 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Atricure, Inc. $89,519 175 payments
  2. Biosense Webster, Inc. $68,115 231 payments
  3. Medical Device Business Services, Inc. $18,863 22 payments
  4. Medtronic, Inc. $15,763 270 payments
  5. Boston Scientific Corporation $12,218 273 payments
  6. Eagle Pharmaceuticals, Inc. $4,098 6 payments
  7. Abbott Laboratories $3,474 29 payments
  8. Philips Electronics North America Corporation $2,217 26 payments
  9. Medtronic Vascular, Inc. $2,133 50 payments
  10. Acutus Medical, Inc. $1,774 10 payments
  11. Other $6,397 244 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $112,356 25 payments
  2. Travel and Lodging $69,174 166 payments
  3. Food and Beverage $40,564 1,142 payments
  4. Honoraria $2,430 1 payment
  5. Education $46 2 payments
Products named General payments · program years 2019–2025
  1. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX $78,986 132 payments
  2. Carto 3 $42,601 182 payments
  3. SYNERGY ABLATION SYSTEM $8,750 23 payments
  4. Thermocool SF $6,987 17 payments
  5. ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2) $6,440 4 payments
  6. ATRICLIP LAA EXCLUSION SYSTEM $3,094 22 payments
  7. WATCHMAN Access System $2,437 52 payments
  8. Micra $2,037 61 payments
  9. (9124) LM Undivided $1,908 12 payments
  10. EnSite Precision Cardiac Mapping System $1,820 7 payments
  11. Other $30,516 765 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 27 drugs

Part D claims

1,550

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$405,645

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

49.2%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 263 $251,135
Farxiga Dapagliflozin Propanediol Brand 49 $57,513
Xarelto Rivaroxaban Brand 42 $40,901
Entresto Sacubitril/Valsartan Brand 31 $36,535
Flecainide Acetate Generic 118 $4,395
Clopidogrel Clopidogrel Bisulfate Brand 278 $3,894
Metoprolol Succinate Generic 154 $2,121
Dofetilide Generic 20 $2,115
Sotalol Sotalol Hcl Brand 83 $1,429
Amiodarone Hcl Generic 28 $814

The 10 drugs with the highest cost, of 27 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 73 billing codes

Paid by Medicare

$375,496

Medicare's payments for the services billed

Medicare patients

972

Average age 77

Services billed

3,456

414 women, 558 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 75%
Arthritis 51%
Ischemic heart disease 41%
Heart failure 40%
Chronic kidney disease 33%
Diabetes 30%
COPD 21%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 8 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
ENTRESTO
$77 31 —
ELIQUIS
$57 263 —
LEQVIO
$38 — —
DUPIXENT
$29 — —
FARXIGA
$18 49 —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 8 in the dashboard with a free account

Records

1,336 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record